Mycophenolate Mofetil Teva

Mycophenolate Mofetil, the active ingredient in Mycophenolate Mofetil Teva, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ transplant rejection and to treat lupus nephritis by dampening immune activity in transplant recipients and patients with renal lupus.

GNH USA supplies Mycophenolate Mofetil Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Mycophenolate Mofetil is used in immunosuppressive regimens for several transplant and autoimmune conditions. - Kidney transplant: reduces the risk of acute and chronic graft rejection. - Liver transplant: helps maintain graft function by suppressing immune‑mediated injury. - Lupus nephritis: controls renal inflammation and preserves kidney function.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: frequent loose stools, may lead to dehydration. - Headache: transient cranial discomfort. - Upper respiratory infection: increased susceptibility to common colds.

Serious or Rare Side Effects: - Bone marrow suppression: leukopenia, anemia, or thrombocytopenia. - Severe infections: opportunistic bacterial, viral, or fungal infections. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Teratogenicity: risk of fetal malformations and pregnancy loss.

Patients receiving Mycophenolate Mofetil require careful monitoring and counseling. - Monitor blood counts: check complete blood count regularly for marrow suppression. - Assess renal function: adjust therapy if creatinine rises. - Avoid live vaccines: immunosuppression can cause vaccine‑derived infection. - Contraindicated in pregnancy: drug is teratogenic; effective contraception is mandatory. - Use contraception: both male and female patients should employ reliable birth control. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Mycophenolate Mofetil can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Cyclosporine: increased mycophenolic acid exposure, raising toxicity risk. - Tacrolimus: synergistic immunosuppression, may require dose adjustment.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR, monitor coagulation. - ACE inhibitors: may exacerbate renal impairment, watch creatinine. - NSAIDs: increase risk of gastrointestinal bleeding and renal dysfunction.